Sudden Cardiac Death: Young People Debate
Full Debate: Read Full DebateJames Frith
Main Page: James Frith (Labour - Bury North)Department Debates - View all James Frith's debates with the Department of Health and Social Care
(1Â month ago)
Commons ChamberI am honoured to be standing at the Dispatch Box as the new Minister for Health Innovation. Let me start by thanking NHS staff for their heroic shifts over the summer months. I also thank the hon. Member for Mid Buckinghamshire (Greg Smith) for bringing this debate forward and speaking with such deep conviction. I am humbled that this is the subject of my first outing in this new role, and I thank him and other Members for their work in this important area. I know that the hon. Gentleman, through his work on the APPG, already met a previous Minister, my hon. Friend the Member for Washington and Gateshead South (Mrs Hodgson), in July.
Reading about it and then listening to the hon. Gentleman’s account again in this debate, we agree that Adam’s death was an absolute tragedy. As a dad, I cannot begin to imagine what Adam’s mum and dad continue to go through, and I pay tribute to them. It goes without saying that I would of course be happy to meet with the hon. Gentleman and Adam’s parents to discuss what more we can do to change the system, to go through the seven requests in detail, and to help save other parents from the same heartbreaking loss that they have endured.
I am determined that the benefits of innovation are felt first and fastest by patients and families, as quickly and safely as possible. That means accelerating the adoption of technology, digital services and the Government’s single patient record, and better integration between our national platforms, so that relevant information about known conditions, family associations and medical history can follow the person across services, professionals and organisations.
Tim Roca (Macclesfield) (Lab)
In January 2023, Mia Jennings died suddenly from a cardiac event. She was a swimming instructor, star apprentice, and, by all accounts, a wonderful young lady. Since her passing, her family have made incredible efforts to raise money for CRY—over £50,000—bringing screening directly to communities across Macclesfield. Will the Minister join me in commending Mia’s family for their extraordinary efforts in her memory?
I never fail to be impressed by the sheer determination of humans who have endured the worst of losses to turn such loss into a positive contribution. Without hesitation, I pay tribute to Mia’s family for their fundraising efforts.
Done properly, innovation can support more joined-up care and personalised services, and faster sharing and implementation of new guidance and learning.
Let me now turn to some of the specific points raised by the hon. Member for Mid Buckinghamshire. NHS England has made changes to the call script in response to new advice from Resuscitation Council UK, issued in November 2023. That advice was given just two months before Adam’s death. It is tragic that it had not yet come into force by the time that Adam stepped on to that pitch. As healthcare professionals, Adam’s mum and dad will know that those changes would have given him a much better chance of survival, as callers now receive advice to begin life support, as well as the certainty of using a defibrillator on a teenager.
The hon. Gentleman raised a number of important points about the NHS pathways system. The challenge we face in improving the sensitivity of cardiac arrest identification is to do so in a way that does not generate false positives. Ongoing performance monitoring of NHS pathways finds that the system accepts over-triage; this is an intentional safety feature of triage systems. As the hon. Gentleman knows, at a time when many ambulance services are under such significant strain, the management of stretched resources is paramount.
The hon. Gentleman is right in saying that NHS England works with the NHS pathways clinical team, ambulance services and specialist organisations, including Resuscitation Council UK, to review data and emerging evidence and to see where we can do better.
Michelle Scrogham (Barrow and Furness) (Lab)
I am grateful for the opportunity to intervene during this important debate. This is an issue that I care about deeply, both because of the impact on young people in Barrow and Furness, and because I have the privilege of serving as chair for the APPG on cardiac risk in the young. I came to be chair of the APPG after learning about the tragic loss of two Barrow and Furness residents, Wilson Shepherd and Vicky Parker. Wilson and Vicky died only two weeks apart and a few miles away from each other in 2023, and both deaths should have been preventable. I pay tribute to their mums, Lesley Mease and Donna Parker, for their tireless campaigning. Will the Government commit to developing a national strategy for the prevention of sudden cardiac death in young people in places like Barrow and Furness and across the country, bringing together screening with experts on cardiac pathology and inherited cardiac conditions and on the identification and investigation of blackouts?
I thank my hon. Friend for her intervention. I would be very happy to discuss those requests in person. I also pay tribute to the families of Wilson and Vicky. The impact of more and more defibs being available is incredibly important, and I am very happy to speak in more detail on that issue.
Amanda Hack
In the summer, I went to Glenfield hospital to talk to staff about the amazing genetic testing done there. Something that strikes me through all the conversations I have had as the former chair of the APPG is how much work could be done in A&E to strengthen that pathway. What can the Minister tell us about looking at ECGs after people have been tested in A&E, which could go back to cardiologists?
I thank my hon. Friend for her intervention; I hope I will cover and do justice to those important points.
NHS pathways also give providers call-level CPR data to support local reviews and improve quality, as well as reviewing data and emerging evidence to see where we must do better. They send quarterly reports to the national clinical assurance group, which is made up of senior clinicians drawn from royal colleges, professional bodies and urgent and emergency care services. These professionals can and often do submit constructive feedback on the way that pathways are run.
At present, NHS clinical staff are trained in CPR, but from April 2027, this will be extended to all NHS staff, including those in A&E. The roll-out of this training will take time, but it will hugely increase the number of people in the country with valuable lifesaving knowledge.
Finally, when it comes to recognising cardiac arrest, I can confirm that the Care Quality Commission does assess call handlers’ skill as part of its inspections. We know that no human system is perfect, and I am all too aware that a list or accounts like this can risk sounding defensive, so let me repeat my openness to sitting with the hon. Member for Mid Buckinghamshire, Adam’s parents and other colleagues to see how and where we can do better and go further.
Turning to the hon. Member’s points about genetics, I am hugely optimistic about the potential of genomics and life sciences over the next 10 years. The NHS clinical genetics services deliver a comprehensive clinical genetics and genetic counselling service for individuals with a family history of genetic conditions, including cardiac conditions. They provide a detailed review of family history that can direct the diagnosis, risk assessment and lifelong clinical management of patients of all ages and their families who have, or are at risk of having, a genomic condition.
The current specification for the clinical genetics services was published more than a decade go under the previous Government and is no longer fit for purpose, not least because this is one of the most innovative fields in healthcare. Today, specialist clinical services simply do not have the capacity or infrastructure to contact family members proactively, except where a particularly high risk has already been identified. For me and my work, it is a clear example of why innovation must help connect our public services.
NHS England’s genomics programme, working with the genomics clinical reference group, has done a review of the 17 regional NHS clinical genetics services. This has shone a light on the challenges to be addressed for this service to match the Government’s expectations.
I am unable to confirm a specific date for the hon. Member for Mid Buckinghamshire, but suffice to say, there is much more to be done before expectations are met by service. On his point about the UK National Screening Committee, it is true that the draft recommendations, which have been consulted on, did not find that the current scientific evidence—